183 related articles for article (PubMed ID: 36755259)
1. CD1C is associated with breast cancer prognosis and immune infiltrates.
Chen X; Zhang J; Lei X; Yang L; Li W; Zheng L; Zhang S; Ding Y; Shi J; Zhang L; Li J; Tang T; Jia W
BMC Cancer; 2023 Feb; 23(1):129. PubMed ID: 36755259
[TBL] [Abstract][Full Text] [Related]
2. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
3. [CD40LG is a novel immune- and stroma-related prognostic biomarker in the tumor microenvironment of invasive breast cancer].
Guo L; Ma Y; Li T; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Sep; 42(9):1267-1278. PubMed ID: 36210698
[TBL] [Abstract][Full Text] [Related]
4. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
5. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
6. CD2 Is a Novel Immune-Related Prognostic Biomarker of Invasive Breast Carcinoma That Modulates the Tumor Microenvironment.
Chen Y; Meng Z; Zhang L; Liu F
Front Immunol; 2021; 12():664845. PubMed ID: 33968066
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
8. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
He Q; Xue S; Wa Q; He M; Feng S; Chen Z; Chen W; Luo X
Medicine (Baltimore); 2021 Apr; 100(17):e25715. PubMed ID: 33907159
[TBL] [Abstract][Full Text] [Related]
9. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
10. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
Liu Y; He X; Yang YI
J Biosci; 2024; 49():. PubMed ID: 38287674
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
12. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
13. Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signaling.
Chen X; Meng C; Wang X; Wu Z; Sun X; Sun C; Zheng L; Li W; Jia W; Tang T
J Cancer Res Clin Oncol; 2024 Feb; 150(2):69. PubMed ID: 38305920
[TBL] [Abstract][Full Text] [Related]
14. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
[TBL] [Abstract][Full Text] [Related]
16. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
17. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.
Deng H; Chen Y; Wang J; An R
PLoS One; 2022; 17(9):e0274897. PubMed ID: 36129956
[TBL] [Abstract][Full Text] [Related]
19. KCNN4 is a potential prognostic marker and critical factor affecting the immune status of the tumor microenvironment in kidney renal clear cell carcinoma.
Chen S; Wang C; Su X; Dai X; Li S; Mo Z
Transl Androl Urol; 2021 Jun; 10(6):2454-2470. PubMed ID: 34295732
[TBL] [Abstract][Full Text] [Related]
20. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
Xiao R; Yang M; Tan Y; Ding R; Li D
Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]